Inhibition of STAT3 abolished the cardioprotective effects of YOD1CKO in Ang II–infused mice, validating the YOD1-STAT3 axis in regulating cardiac hypertrophy. The gene discussed is YOD1; the disease is cardiac hypertrophy.